Research Projects

Vincent V.C. Woo Chinese Medicine Clinical Research Institute has been conducting clinical research in Chinese medicine, mainly covering the following target diseases:

Projects_no outline Projects_no outline
Main target diseases

 

Mental Health
  • Effectiveness of the Chinese medicine and integrative treatment with counselling in major depressive disorder: A stepped wedge cluster randomized controlled trial

Stroke
  • Efficacy of the CHM Teabag in Decreasing Stroke Risk among Elderly People in Hong Kong: A Stepped Wedge Cluster Randomized Trial

  • Real-world clinical cohort study of TCM Stroke Rehabilitation

COVID-19
  • Weekly symptom profiles of nonhospitalized individuals infected with SARS-CoV-2 during the Omicron outbreak in Hong Kong: A retrospective observational study from a telemedicine center

  • Prevalence and risk factors of long COVID 6-12 months after infection with the Omicron variant among non-hospitalized patients in Hong Kong

  • Effectiveness of Chinese herbal medicine in patients with COVID-19 during the Omicron wave in Hong Kong: a retrospective case-controlled study

  • The efficacy and safety of a Chinese herbal medicine (Shenlingcao oral liquid) for treating long COVID-associated fatigue: a double-blinded, placebo-controlled, randomized clinical trial

Diabetes Mellitus
  • Investigation about the Prevalence, Chinese Medicine Syndrome Types and its Underlying Mechanism of Long COVID among Diabetic Patients in Hong Kong 

  • Investigation of Changes in Insulin Sensitivity in Healthy Volunteers, Pre-diabetes Mellitus and Diabetes Mellitus Patients after the Vaccination of BioNTech

Ulcerative Colitis
  • Efficacy and Safety of Chinese Herbal Formula CDD-2103 for Remission Maintenance of Ulcerative Colitis: A Randomized, Double-blinded, Placebo-controlled Trial

  • A longitudinal observational study of the molecular dynamics and microbial profile in mediating relapse-remission in ulcerative colitis patients

Constipation
  • A randomised, double-blind, placebo-controlled clinical trial to determine the effects of MaZiRenWan granules on functional constipation and constipation-predominant irritable bowel syndrome

  • A longitudinal observational study to characterise gut microbiota in the spectrum of functional constipation and constipation-predominant irritable bowel syndrome

Irritable bowel syndrome
  • A Single-Arm Study of a Chinese Herbal Medicine (CDD-2105) Formula for the constipation-predominant irritable bowel syndrome (IBS-C)

  • Efficacy and safety of a Chinese Herbal Medicine (CDD-2105) for the constipation-predominant irritable bowel syndrome (IBS-C): a randomized, double-blinded, placebo-controlled clinical trial